Serban Negoita

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Health Insurance

Radical Prostatectomy

Prostate Cancer

Top Venues

Journal of the National Cancer Institute. Monographs

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Huann-Sheng Chen, Serban Negoita, Steve Schwartz, Elizabeth Hsu, Jennifer Hafterson, Linda Coyle, Jennifer Stevens, Anna Fernandez, Mary Potts, Eric J Feuer
Toward real-time reporting of cancer incidence: methodology, pilot study, and SEER Program implementation. Journal of the National Cancer Institute. Monographs 2024 (65) (2024)
Steve Friedman, Serban Negoita
History of the Surveillance, Epidemiology, and End Results (SEER) Program. Journal of the National Cancer Institute. Monographs 2024 (65) (2024)
Nita H Mukand, Ekaterina Chirikova, Daphne Y Lichtensztajn, Serban Negoita, Tamer Aboushwareb, John Bennett, James D Brooks, John T Leppert, Benjamin I Chung, Christopher I Li, Stephen M Schwartz, Susan T Gershman, Tabassum Zarina Insaf, Bozena M Morawski, Antionette Stroup, Xiao-Cheng Wu, Jennifer Anne Doherty, Valentina I Petkov, Joao Paulo Zambon, Scarlett Lin Gomez, Iona Cheng
Assessing sociodemographic and regional disparities in Oncotype DX Genomic Prostate Score uptake. Cancer (2024)
Steve Friedman, Serban Negoita
History of the Surveillance, Epidemiology, and End Results (SEER) Program. Journal of the National Cancer Institute. Monographs 2024 (65) (2024)
Serban Negoita, Huann-Sheng Chen, Pamela V Sanchez, Recinda L Sherman, S Jane Henley, Rebecca L Siegel, Hyuna Sung, Susan Scott, Vicki B Benard, Betsy A Kohler, Ahmedin Jemal, Kathleen A Cronin
Annual Report to the Nation on the Status of Cancer, part 2: Early assessment of the COVID-19 pandemic's impact on cancer diagnosis. Cancer (2023)
Amina Chtourou, Pamela V Sanchez, Todd Golden, Huann-Sheng Chen, Stephen M Schwartz, Xiao-Cheng Wu, Brenda Y Hernandez, Jovanka N Harrison, Lynne Penberthy, Serban Negoita
Impact on the Volume of Pathology Reports Before and During the COVID-19 Pandemic in SEER Cancer Registries. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
J Bryan Iorgulescu, Chuxuan Sun, Corey Neff, Gino Cioffi, Catherine Gutierrez, Carol Kruchko, Jennifer Ruhl, Kristin A Waite, Serban Negoita, Jim Hofferkamp, Tarik Tihan, Roger E McLendon, Daniel J Brat, Quinn T Ostrom, Jill S Barnholtz-Sloan
Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States. Neuro-oncology 24 (11) (2022)
Kathleen A Cronin, Susan Scott, Albert U Firth, Hyuna Sung, S Jane Henley, Recinda L Sherman, Rebecca L Siegel, Robert N Anderson, Betsy A Kohler, Vicki B Benard, Serban Negoita, Charles Wiggins, William G Cance, Ahmedin Jemal
Annual report to the nation on the status of cancer, part 1: National cancer statistics. Cancer 128 (24) (2022)
Serban Negoita, Angela Mariotto, Vicki Benard, Betsy A Kohler, Ahmedin Jemal, Lynne Penberthy
Reply to annual report to the nation on the status of cancer, part II: Recent changes in prostate cancer trends and disease characteristics. Cancer 125 (2) (2018)